Share the post "Global Health ‘s Q3 2024-25 Latest News: Profit Rises by 15.64% YoY"
Highlights
🔹 The presented financial data is Consolidated to provide a comprehensive overview of the company performance. 🔹 Sales over the Year and quarter: The company experienced a substantial growth of 13.31 % in the past year, decrease in net sales/revenue by -1.37 %. 🔹 Income over the Year and quarter: There has been decline in other income over the past year which is -26.93 %, Marginal decrease of -12.03% in other income during this quarter. 🔹 Profit over the Year and quarter: Significant improvement in profitability for Global Health Limited. Notable increase of 15.64 % in net profit Year to Year, Global Health Limited’s profitability increased by 9.2 % in this quarter. 🔹 EPS over the Year and quarter: EPS increased by 15.40 % Year to Year. EPS increased by 9.24 % in previous quarter. Positive impact on shareholders.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 832.602 Cr | Rs. 956.555 Cr | Rs. 943.436 Cr | -1.37 % | + 13.31 % |
Expenses | Rs. 620.51 Cr | Rs. 728.26 Cr | Rs. 705.67 Cr | -3.1 % | + 13.72 % |
Operating Profit | Rs. 212.09 Cr | Rs. 228.3 Cr | Rs. 237.77 Cr | + 4.15 % | + 12.11 % |
OPM % | 25.47 % | 23.87 % | 25.2 % | + 1.33 % | -0.27 % |
Other Income | Rs. 21.931 Cr | Rs. 18.216 Cr | Rs. 16.024 Cr | -12.03 % | -26.93 % |
Interest | Rs. 17.68 Cr | Rs. 15.98 Cr | Rs. 16.28 Cr | + 1.88 % | -7.92 % |
Depreciation | Rs. 43.98 Cr | Rs. 49.43 Cr | Rs. 48.45 Cr | -1.98 % | + 10.16 % |
Profit before tax | Rs. 172.36 Cr | Rs. 181.11 Cr | Rs. 189.06 Cr | + 4.39 % | + 9.69 % |
Tax % | 28.33 % | 27.76 % | 24.44 % | -3.32 % | -3.89 % |
Net Profit | Rs. 123.54 Cr | Rs. 130.82 Cr | Rs. 142.86 Cr | + 9.2 % | + 15.64 % |
EPS in Rs | Rs. 4.6 | Rs. 4.87 | Rs. 5.32 | + 9.24 % | + 15.65 % |
Today, we’re looking at Global Health Limited’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 13.31 %. However, it did see a marginal slip of -1.37 % from the previous quarter. Expenses decreased slightly by -3.1 % quarter-on-quarter, aligning with the annual rise of 13.72 %. Operating profit, while up 12.11 % compared to last year, faced a quarter-on-quarter increase of 4.15 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -0.27 %, but an expansion of 1.33 % sequentially. Other income fell by -12.03 % compared to the last quarter, despite an annual decline of -26.93 %. Interest expenses surged remarkably by 1.88 % from the previous quarter, yet the year-over-year decrease remains at a moderate -7.92 %. Depreciation costs fell by -1.98 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 10.16 %. Profit before tax grew annually by 9.69 % but saw an increase from the preceding quarter by 4.39 %.
Tax expenses as a percentage of profits decreased slightly by -3.89 % compared to last year, with a more notable quarter-on-quarter decrease of -3.32 %. Net profit rose by 15.64 % year-on-year but experienced a 9.2 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 15.65 % but a quarterly rise of 9.24 %. In summary, Global Health Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 832.602 Cr | Rs. 956.555 Cr | Rs. 943.436 Cr | -1.37 % | + 13.31 % |
Expenses | Rs. 620.51 Cr | Rs. 728.26 Cr | Rs. 705.67 Cr | -3.1 % | + 13.72 % |
Operating Profit | Rs. 212.09 Cr | Rs. 228.3 Cr | Rs. 237.77 Cr | + 4.15 % | + 12.11 % |
Net Profit | Rs. 123.54 Cr | Rs. 130.82 Cr | Rs. 142.86 Cr | + 9.2 % | + 15.64 % |
EPS in Rs | Rs. 4.6 | Rs. 4.87 | Rs. 5.32 | + 9.24 % | + 15.65 % |
In reviewing Global Health Limited’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 13.31 % year-on-year growth, although there was a slight dip of -1.37 % from the previous quarter. Expenses rose by 13.72 % compared to the previous year, with a decrease of -3.1 % quarter-on-quarter. Operating Profit surged by 12.11 % annually, and saw a 4.15 % increase from the last quarter.
Net Profit showed yearly increase of 15.64 %, and experienced a 9.2 % increase from the previous quarter. Earnings Per Share (EPS) rose by 15.65 % annually, however rose by 9.24 % compared to the last quarter. In essence, while Global Health Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.